Schedule dependence of activity of the amsacrine analogue CI-921 towards P388 leukaemia and Lewis lung carcinoma
- 1 November 1985
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 21 (11) , 1337-1341
- https://doi.org/10.1016/0277-5379(85)90314-1
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- SYNTHESIS, ANTITUMOR-ACTIVITY, AND DNA-BINDING PROPERTIES OF A NEW DERIVATIVE OF AMSACRINE, N-5-DIMETHYL-9-[(2-METHOXY-4-METHYLSULFONYLAMINO)PHENYLAMINO]-4-ACRIDINECARBOXAMIDE1984
- Divergent activity of derivatives of amsacrine (m-AMSA) towards Lewis lung carcinoma and P388 leukaemia in miceEuropean Journal of Cancer and Clinical Oncology, 1983
- Current results of the screening program at the division of cancer treatment, national cancer institutePublished by Elsevier ,1981
- PHASE-I AND PHASE-II TRIAL OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-META-ANISIDIDE IN PATIENTS WITH ACUTE-LEUKEMIA1980
- The experimental antitumour properties of three congeners of the acridylmethanesulphonanilide (AMSA) seriesPublished by Elsevier ,1974